Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

Vitiligo

CASP7 · rs12771452

Strength of the evidence

1 / 4

Its strongest genetic-study result is p = 10−11, with 1 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 2,853 European ancestry cases and 37,405 European ancestry controls; replicated in 1,827 European ancestry cases and 2,181 European ancestry controls.

The effect Each copy of the G allele carried 1.22 times the odds of Vitiligo (95% confidence interval 1.15-1.28); p = 4 × 10−12.

How common The G allele had a frequency of about 74% in the people studied.

Where it sits Chromosome 10, band 10q25.3 — in an intron of CASP7.

How common each version is

AG
Korean KRGDB
A 39.7% · G 60.3%
Korean Korea4K
A 39.6% · G 60.4%
Korean Korea1K
A 39.1% · G 60.9%
Japanese ToMMo
A 46.8% · G 53.2%
Vietnamese
A 36.9% · G 63.1%
World gnomAD
A 23.1% · G 76.9%
World 1000 Genomes
A 25.1% · G 74.9%
World TOPMed
A 22.7% · G 77.3%

By ancestry gnomAD

East Asian
A 41.4% · G 58.6%
European (non-Finnish)
A 26.2% · G 73.8%
African / African American
A 14.6% · G 85.4%
South Asian
A 23.8% · G 76.2%
Admixed American (Latino)
A 23.9% · G 76.1%
Middle Eastern
A 19.4% · G 80.6%
Finnish
A 27.2% · G 72.8%
Ashkenazi Jewish
A 18.3% · G 81.7%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

A/A No copy of the version the research linked to Vitiligo. This is the starting point the study compared everyone against.
A/G One copy of the version the research linked to Vitiligo. That is a smaller link than two copies.
G/G Two copies of the version the research linked to Vitiligo. That is the strongest link of the three results. A link in a study is not a diagnosis.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Vitiligo (rs12771452). MyGeneLog™. https://www.mygenelog.com/variants/rs12771452

← See all variants